Tag: Australian Medical Cannabis

MediPharm Labs Receives Australian Licence to Import Drugs

BARRIE, Ontario, Jan. 31, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis...
- January 31st, 2020 at 7:23 am

Canopy Growth Announces Sale of Stake in AusCann

The companies will continue to collaborate in the Australian market SMITHS FALLS, ON, Oct. 15, 2019 /PRNewswire/ – Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“Canopy Growth”) has sold...
- October 15th, 2019 at 7:58 am

MediPharm Labs Receives Australian Cannabis License

MediPharm Labs Australia Awarded Cannabis Manufacturing Licence From Office of Drug Control – Establishes Asia-Pacific Foothold TORONTO, May 21, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX:...
- May 21st, 2019 at 5:18 pm

MedReleaf Australia Commences Commercial Operations

Indica Industries Pty Ltd, the partner of Canadian licensed producer MedReleaf (TSX: LEAF) (OTC: MEDFF) that is operating as MedReleaf Australia, has commenced commercial operations. The company, which received its...
- February 4th, 2018 at 9:41 pm

ABcann Granted Australian Import License

  ABCANN GLOBAL CORPORATION (TSXV: ABCN) (“ABcann” or the “Company”) is pleased to announce that its wholly-owned subsidiary, ABcann Australia Pty Ltd. (“ABcann Australia”), has received an import license from...
- January 18th, 2018 at 7:53 am

Elixinol Global Begins Trading in Australia

Elixinol Global Initial Public Offering (“IPO”) Elixinol Global Limited (the “Company”) is pleased to announce the successful completion of its initial public offering (“IPO”) of shares and its admission...
- January 7th, 2018 at 9:02 pm

Cann Group Raised AUS$58.7 Million

  Cann Group ( ASX: CAN) (OTC: CNGGF) announced an increase to its capital raise, boosting it to $58.7, seling  by shares $2.50 in a deal underwritten by Canaccord...
- December 3rd, 2017 at 10:47 pm

Australian Cannabis Producer AusCann Raises $12mm

AusCann Secures $12 Million In Institutional Placement 19 May 2017 Highlights Successful Placement raising $12 million with strong interest from new institutional investors both domestic and global 24,000,000 shares...
- May 19th, 2017 at 7:03 am

Cannabis Now a Global Investment Opportunity

Readers of New Cannabis Ventures likely recall how we alerted to the huge opportunities in Canada last June, and the Canadian market continues to evolve as a leader in the...
- May 11th, 2017 at 10:20 am